Quell is a 100% drug free, non-surgical technology that is FDA cleared for symptomatic relief and management of chronic pain. This innovative system combines advanced neurotechnology in a wearable format with a sophisticated app for users to personalize and control therapy while tracking relevant health metrics.
READ MOREVisit Quell videoQuell is wearable pain relief technology that lives with you day and night. Quell stimulates sensory nerves with safe and precise electrical pulses to trigger a natural pain relief response.
The innovative Quell system is personalized to meet your needs and is smart enough to adjust therapy to changes during sleep and can even compensate for changes in the weather. Users have the option to personalize and manage their therapy discreetly via the Quell app, which offers therapy utilization, sleep, activity and pain tracking. Quell offers those living with chronic pain another option. Quell is available online at QuellRelief.com, and through select healthcare professionals.
The Quell Health Cloud is one of the largest chronic pain databases. The deidentified user data collected from Quell users has already powered research published in peer-reviewed medical journals and has been presented at many scientific conferences.
READ MOREThe Quell Health Cloud is already one of the largest pain databases in the world with over 15 million hours of patient data including usage, therapy, sleep activity and gait. This data is fueling scientific research and Quell product improvements.
A highly accurate and efficient point-of-care test for detecting diabetic peripheral neuropathy, one of the most common and costly complications of diabetes.
READ MOREVISIT DPNCheckDPNCheck is a fast, accurate, and quantitative nerve conduction test that is used to evaluate systemic neuropathies such as diabetic peripheral neuropathy (DPN). It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor DPN. The device measures nerve conduction velocity and response amplitude of the sural nerve, a nerve in the lower leg and ankle. These parameters are widely recognized as sensitive and specific biomarkers of DPN.
A point-of-care diagnostic platform for assessing common neuropathies.
READ MOREThe ADVANCE System is a NeuroMetrix legacy product. Although the device is no longer marketed, we maintain and supply a large customer base that continues to utilize our disposable electrodes. For users, the ADVANCE System provides efficient and convenient nerve conduction studies at the point-of-care setting. ADVANCE allows physicians to immediately assess and a establish treatment plan for their patients. ADVANCE is used with proprietary nerve-specific electrode arrays for accuracy and standardization.
